This finding also supports our previous data, demonstrating that IL-26 also plays a role in the clinical setting, where Gram-negative bacteria constitute an important pathogenic stimulus for exacerbations of diseases such as pneumonia and COPD (Che et al., 2014; Che et al., 2018). The gene discussed is IL26; the disease is chronic obstructive pulmonary disease.